Cystic Fibrosis Foundation CEO and leadership

Michael Boyle, MD, is president and chief executive officer. Prior to his appointment as president and CEO, Dr. Boyle served as senior vice president, therapeutics development at the Cystic Fibrosis Foundation from 2015-2019. In that role, Dr. Boyle shaped the Foundation's clinical research strategy, overseeing the clinical development programs of new treatments for the CF Foundation, as well as the Foundation's Therapeutics Development Network of 92 academic research centers.

Dr. Boyle is internationally known for his clinical research and for his work to improve care for adults with CF. He served as both an investigator in the clinical study of Kalydeco® and principal investigator of the pivotal trial that led to approval of the first combination treatment, Orkambi®. Dr. Boyle completed his medical training at Johns Hopkins University, including a fellowship in pulmonary and critical care medicine, before joining the medical faculty in 1999. Dr. Boyle founded the Johns Hopkins University Adult CF Program -- one of the largest in the United States -- in 1999 and served as director of that center for close to two decades. Today, he is an adjunct professor of medicine at Johns Hopkins, where he continues to see patients. In addition to his medical background, Dr. Boyle has completed training in nonprofit management at both Johns Hopkins and Harvard University.

Senior Information Technology Executive with diverse experience optimizing a mission critical technology services portfolio for the world's leader in a search for a cure for cystic fibrosis and previously for the world's leading provider of diagnostic testing services and for the nation’s leading supplier of competitive electricity to large commercial and industrial customers...

...but really just a brutally honest techie exec who truly believes in getting technology out of the way of real business, pontificator of all things green, energy & healthcare related, but NOT a biz monkey (thanks Seth Godin), defender against inefficient consumerism, protector of young swimmers, the real Internet pioneer (sorry Mr. Gore), Guinness collector & aficionado, rider of whitewater, philanthropist, Apple & Tesla fanboy and award winning author of Rules of Life, 3 Principles of 3, Parenting 101 & The 3 C's.

Jack Mahler is a Chief Investment Officer at Cystic Fibrosis Foundation.

Marin Goings is a Chief of Strategy at Cystic Fibrosis Foundation and is based in Bethesda, Maryland. He has worked as Strategist at Cystic Fibrosis Foundation; Graduate Student Researcher at California Center for Innovative Transportation; and Intern, Project Planning and Implementation Division at National Capital Planning Commission. Marin attended University of California Berkeley between 2008 and 2009, University of Virginia between 2004 and 2008, and Harvard Business School between 2012 and 2014.

Michael Boyle, MD, is president and chief executive officer. Prior to his appointment as president and CEO, Dr. Boyle served as senior vice president, therapeutics development at the Cystic Fibrosis Foundation from 2015-2019. In that role, Dr. Boyle shaped the Foundation's clinical research strategy, overseeing the clinical development programs of new treatments for the CF Foundation, as well as the Foundation's Therapeutics Development Network of 92 academic research centers.

Dr. Boyle is internationally known for his clinical research and for his work to improve care for adults with CF. He served as both an investigator in the clinical study of Kalydeco® and principal investigator of the pivotal trial that led to approval of the first combination treatment, Orkambi®. Dr. Boyle completed his medical training at Johns Hopkins University, including a fellowship in pulmonary and critical care medicine, before joining the medical faculty in 1999. Dr. Boyle founded the Johns Hopkins University Adult CF Program -- one of the largest in the United States -- in 1999 and served as director of that center for close to two decades. Today, he is an adjunct professor of medicine at Johns Hopkins, where he continues to see patients. In addition to his medical background, Dr. Boyle has completed training in nonprofit management at both Johns Hopkins and Harvard University.